EGFR and non-small cell lung carcinoma: Unsupervised hierarchical clustering analysis based on the markers of interest revealed that NSCLC patients with a higher CD8/FOXP3 ratio and low PD-1/PD-L1 immune checkpoint expression (cluster 3) and without EGFR mutation were likely to experience local disease control.